Craig Bas­son tells us why he leapt from NI­BR to Boston Phar­ma; Ex-BMS Part­ner Cy­tomX finds new CMO in Al­li­son Han­nah

Craig Bas­son (Jon Chomitz) 

Se­nior year, Craig Bas­son would walk to the store­room in Roslyn High and check on the rats his sci­ence teacher had or­dered him.

The ex­per­i­ment was sim­ple. Bas­son cas­trat­ed the rats. He wait­ed for the cells in the ep­ithe­li­um to de­cay, and then he in­ject­ed testos­terone or es­tro­gen to see if they re­grew. If he didn’t have the right mi­cro­scope to an­a­lyze re­sults, he whee­dled for time at a lo­cal uni­ver­si­ty and car­ried his sam­ples there.

“These days it would be com­plete­ly un­ac­cept­able,” Bas­son told End­points News, cit­ing the eth­i­cal con­cerns of a high school­er do­ing un­ap­proved an­i­mal ex­per­i­ments. “It just wasn’t as well ap­pre­ci­at­ed in the 1970s.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER